Expression of an Activated Erythropoietin or a Colony-stimulating Factor 1 Receptor by Pluripotent Progenitors Enhances Colony Formation but Does Not Induce Differentiation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1994 Aug 2

PMID 8052607

Citations 11

Authors

P N Pharr

M Ogawa

A Hofbauer

G D Longmore

Affiliations

Soon will be listed here.

Abstract

Whether the presence of specific receptors on the surface of developing cells is the cause or consequence of lineage restriction is not known. If activation of specific receptors is the driving event in differentiation, the premature expression of specific receptors would promote differentiation along that pathway. In this study pluripotent progenitors, obtained from blast cell colonies (pooled or individual) of 5-fluorouracil-treated mice, were infected with retroviral vectors containing either an activated receptor for erythropoietin (EPO), an erythroid progenitor growth factor, or the receptor for colony-stimulating factor 1 (CSF-1), a macrophage growth factor. These receptors exhibit expression patterns restricted to committed progenitors. The developmental potential of infected pluripotent progenitors was not changed, although they expressed the exogenous genes, suggesting that in these cells activation of lineage-specific receptors does not induce differentiation. Acquisition of a constitutively activated EPO receptor allowed erythroid development in mixed colonies in the absence of EPO, as expected. Infection of progenitors with a virus containing the CSF-1 receptor promoted the development of granulocyte/macrophage (GM) colonies but did not alter the differentiation potential of either colony-forming unit (CFU)-GM or CFU-mix.

Citing Articles

Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress.

Seyfried A, Maloney J, MacNamara K Front Immunol. 2020; 11:1499.

PMID: 32849512 PMC: 7396643. DOI: 10.3389/fimmu.2020.01499.

Progress in detecting cell-surface protein receptors: the erythropoietin receptor example.

Elliott S, Sinclair A, Collins H, Rice L, Jelkmann W Ann Hematol. 2013; 93(2):181-92.

PMID: 24337485 PMC: 3890056. DOI: 10.1007/s00277-013-1947-2.

The effect of erythropoietin on normal and neoplastic cells.

Elliott S, Sinclair A Biologics. 2012; 6:163-89.

PMID: 22848149 PMC: 3402043. DOI: 10.2147/BTT.S32281.

Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion.

Negre O, Fusil F, Colomb C, Roth S, Gillet-Legrand B, Henri A Blood. 2011; 117(20):5321-31.

PMID: 21436071 PMC: 3109707. DOI: 10.1182/blood-2010-01-263582.

The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium.

Brisken C, Socolovsky M, Lodish H, Weinberg R Proc Natl Acad Sci U S A. 2002; 99(22):14241-5.

PMID: 12381781 PMC: 137868. DOI: 10.1073/pnas.222549599.

References

Migliaccio A, Migliaccio G, DAndrea A, Baiocchi M, Crotta S, Nicolis S . Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci U S A. 1991; 88(24):11086-90. PMC: 53078. DOI: 10.1073/pnas.88.24.11086. View

Borzillo G, Ashmun R, Sherr C . Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol Cell Biol. 1990; 10(6):2703-14. PMC: 360630. DOI: 10.1128/mcb.10.6.2703-2714.1990. View

Witthuhn B, Quelle F, Silvennoinen O, Yi T, Tang B, Miura O . JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993; 74(2):227-36. DOI: 10.1016/0092-8674(93)90414-l. View

Pharr P, Ogawa M, HANKINS W . In vitro retroviral transfer of ras genes to single hemopoietic progenitors. Exp Hematol. 1987; 15(4):323-30. View

Rambaldi A, Young D, Griffin J . Expression of the M-CSF (CSF-1) gene by human monocytes. Blood. 1987; 69(5):1409-13. View

Roussel M, Downing J, Rettenmier C, Sherr C . A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. Cell. 1988; 55(6):979-88. DOI: 10.1016/0092-8674(88)90243-7. View

Bourette R, Mouchiroud G, Ouazana R, Morle F, Godet J, Blanchet J . Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine pluripotent hematopoietic NFS-60 cells induces long-term proliferation in response to CSF-1 without loss of erythroid differentiation potential. Blood. 1993; 81(10):2511-20. View

Bruce W, McCulloch E . THE EFFECT OF ERYTHROPOIETIC STIMULATION ON THE HEMOPOIETIC COLONY-FORMING CELLS OF MICE. Blood. 1964; 23:216-32. View

Kinashi T, Lee K, Ogawa M, Tohyama K, Tashiro K, Fukunaga R . Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture. J Exp Med. 1991; 173(5):1267-79. PMC: 2118849. DOI: 10.1084/jem.173.5.1267. View

10.

Ullrich A, Schlessinger J . Signal transduction by receptors with tyrosine kinase activity. Cell. 1990; 61(2):203-12. DOI: 10.1016/0092-8674(90)90801-k. View

11.

Stahl N, Boulton T, Farruggella T, Ip N, Davis S, Witthuhn B . Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 1994; 263(5143):92-5. DOI: 10.1126/science.8272873. View

12.

Anderson D, Lyman S, Baird A, Wignall J, Eisenman J, Rauch C . Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell. 1990; 63(1):235-43. DOI: 10.1016/0092-8674(90)90304-w. View

13.

Wiktor-Jedrzejczak W, Ratajczak M, Ptasznik A, Sell K, Ahmed-Ansari A, Ostertag W . CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol. 1992; 20(8):1004-10. View

14.

Cosman D, Lyman S, Idzerda R, Beckmann M, Park L, Goodwin R . A new cytokine receptor superfamily. Trends Biochem Sci. 1990; 15(7):265-70. DOI: 10.1016/0968-0004(90)90051-c. View

15.

Yoshimura A, Longmore G, Lodish H . Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature. 1990; 348(6302):647-9. DOI: 10.1038/348647a0. View

16.

Longmore G, Pharr P, Neumann D, Lodish H . Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood. 1993; 82(8):2386-95. View

17.

Mayani H, Dragowska W, Lansdorp P . Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines. J Cell Physiol. 1993; 157(3):579-86. DOI: 10.1002/jcp.1041570318. View

18.

REISSMANN K, Udupa K . Effect of erythropoietin on proliferation of erythropoietin-responsive cells. Cell Tissue Kinet. 1972; 5(6):481-9. DOI: 10.1111/j.1365-2184.1972.tb00386.x. View

19.

Suda T, Suda J, Ogawa M . Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors. Proc Natl Acad Sci U S A. 1984; 81(8):2520-4. PMC: 345094. DOI: 10.1073/pnas.81.8.2520. View

20.

REISSMANN K, Samorapoompichit S . Effect of erythropoietin on proliferation of erythroid stem cells in the absence of transplantable colony-forming units. Blood. 1970; 36(3):287-96. View